KERLONE
BETAXOLOL HYDROCHLORIDE
Approval overview KERLONE is listed in Drugs@FDA under application 019507 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAXOLOL HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-08-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview KERLONE is listed in Drugs@FDA under application 019507 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BETAXOLOL HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-08-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.